Adaptimmune Therapeutics (ADAP) null Earnings

9MayConfirmed
Aug 17
Nov 17
Mar 18
May 18
-0.3
-0.2
-0.11
-0.01

Details

Expected EPS
-0.24
Actual EPS
-0.22
Surprise EPS
0.02
Surprise Percent
+8.33%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.22 per share for .

0 Comments

Share your thoughts